Apologies for the misreading/misinterpretation.
Maybe the stem cell research teams already have enough excitementthis would just be too much.
Maybe the organisers want the revascularisation people to start thinking outside the box a little. Though this approach with MPC-150-IM would depend a bit on the urgency of the situation.
Ann: End-Stage HF Results Selected For AHA Scientific Sessions, page-51
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.000(0.00%) |
Mkt cap ! $1.295B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.13 | $1.373M | 1.203M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 32059 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 9857 | 5 |
View Market Depth
| Last trade - 12.47pm 22/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |